Prices of Orphan Drugs in Four Western European Countries Before and After Market Exclusivity Expiry: A Cross-Country Comparison of List Prices and Purchase Prices

BACKGROUND: Increasing pharmaceutical expenditure challenges the sustainability and accessibility of healthcare systems across Europe. Confidentiality restraints hinder assessment of actual prices of Orphan Medicinal Products (OMPs). Hence, we assessed the real prices of brand-name OMPs around marke...

Descripción completa

Detalles Bibliográficos
Autores principales: Dane, Aniek, Klein Gebbink, Anne-Sophie, Brugma, Jan-Dietert, Degrassat-Théas, Albane, Hug, Martin J., Houlind, Morten B., Paubel, P., van der Kuy, P. Hugo M., Uyl-de Groot, Carin A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628053/
https://www.ncbi.nlm.nih.gov/pubmed/37751107
http://dx.doi.org/10.1007/s40258-023-00832-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10628053/
https://www.ncbi.nlm.nih.gov/pubmed/37751107
http://dx.doi.org/10.1007/s40258-023-00832-6

Ejemplares similares